FDA.reportPublic FDA data

1 ML tildrakizumab-asmn 100 MG/ML Prefilled Syringe

RxCUI
2053453
RxNorm name
1 ML tildrakizumab-asmn 100 MG/ML Prefilled Syringe
Display name
1 ML tildrakizumab-asmn 100 MG/ML Prefilled Syringe
Full name
1 ML tildrakizumab-asmn 100 MG/ML Prefilled Syringe
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761067Ilumyatildrakizumab-asmn351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c6a322bb-51b9-4f0e-8642-62a9682ffcdetildrakizumab-asmn 100 MG in 1 ML Prefilled Syringe [PSN] · 1 ML tildrakizumab-asmn 100 MG/ML Prefilled Syringe [SCD] · tildrakizumab-asmn 100 MG per 1 ML Prefilled Syringe [SY]318These highlights do not include all the information needed to use ILUMYA safely and effectively. See full prescribing information for ILUMYA. ILUMYA ® (tildrakizumab-asmn) injection, for subcutaneous use Initial U.S. Approval: 201820251225